Does institutional patient accrual volume impact overall survival in patients with inoperable non‐small‐cell lung cancer receiving radical (chemo)radiation? A secondary analysis of TROG 99.05-Reference-Cited by-同舟云学术

Does institutional patient accrual volume impact overall survival in patients with inoperable non‐small‐cell lung cancer receiving radical (chemo)radiation? A secondary analysis of TROG 99.05

Published:2020-05-11 Issue:4 Volume:64 Page:556-562
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:J Med Imaging Radiat Oncol

Author:

Tan Mun Yee¹^ORCID,Fisher Richard²,Ball David¹³^ORCID

Affiliation:

1. Department of Radiation Oncology Peter MacCallum Cancer Centre Melbourne Victoria Australia

2. Cancer Research Division Department of Radiation Oncology Peter MacCallum Cancer Centre Melbourne Victoria Australia

3. The Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1754-9485.13042

Reference18 articles.

1. Canceraustralia.org. Lung cancer statistics. [updated 2019 Aug 26

2. cited 2020 Mar 16]. Available from:https://lung‐cancer.canceraustralia.gov.au/statistics.

3. Revisions in the International System for Staging Lung Cancer

4. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

5. Hospital and Physician Volume or Specialization and Outcomes in Cancer Treatment: Importance in Quality of Cancer Care

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer: Current Status and Future Perspectives;Lung Cancer - Modern Multidisciplinary Management;2021-06-02

2. Hospital volume and physician volume in association with survival in patients with nasopharyngeal cancer after radiation therapy;Radiotherapy and Oncology;2020-10